Modelling ischaemia in vitro: Effects of temperature and glucose concentration on dopamine release evoked by oxygen and glucose depletion in a mouse brain slice

Journal of Neuroscience Methods

Volumn 202, Issue 2, 2011, Pages 165-172

  Davidson, C ^a   Chauhan, N K ^a   Knight, S ^a   Gibson, C L ^a   Young, A M J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Brain slice; Dopamine; Hypoglycaemia; Hypoxia; Mouse; Voltammetry

Indexed keywords

DOPAMINE; GLUCOSE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE RELEASE; IN VITRO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RELIABILITY; TEMPERATURE; TRANSGENIC MOUSE;

ANIMALS; BODY TEMPERATURE; BRAIN; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROCHEMICAL TECHNIQUES; GLUCOSE; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICE; MICE, INBRED C57BL; NEUROCHEMISTRY; ORGAN CULTURE TECHNIQUES; PRESYNAPTIC TERMINALS;

EID: 80052923560     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.05.019     Document Type: Article

References (35)

1. Armstrong-James M., Millar J. Carbon fibre microelectrodes. J Neurosci Methods 1979, 1:279-287.
2. Belayev L., Busto R., Zhao W., Fernandez G., Ginsberg M.D. Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-l-lysine: neurological and histological validation. Brain Res 1999, 833:181-190.
3. Benedek A., Moricz K., Juranyi Z., Gigler G., Levay G., Harsing L.G., et al. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res 2006, 1116:159-165.
4. Brannan T., Weinberger J., Knott P., Taff I., Kaufman H., Togaski D., et al. Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes. Stroke 1987, 18:108-110.
5. Buyukuysal R.L., Mete B. Anoxia-induced dopamine release from rat striatal slices: involvement of reverse transport mechanism. J Neurochem 1999, 72:1507-1515.
6. Cole D.J., Drummond J.C., Ghazal E.A., Shapiro H.M. A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC). Acta Neuropathol 1990, 80:152-155.
7. Davidson C., Coomber B., Stamford J.A., Gibson C.L., Young A.M.J. Effect of pre-ischaemic conditioning on hypoxic depolarization of dopamine efflux in the rat caudate brain slice measured in real-time with fast cyclic voltammetry. Proceedings of the British Pharmacological Society 2008, http://www.pa2online.org/abstracts/Vol6Issue4abst138P.pdf.
8. Dettmers C., Hartmann A., Rommel T., Kramer S., Pappata S., Young A., et al. Immersion and perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) compared to mitochondrial enzymes 6hours after MCA-occlusion in primates. Neurol Res 1994, 16:205-208.
9. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
10. Doyle K.P., Simon R.P., Stenzel-Poore M.P. Mechanisms of ischemic brain damage. Neuropharmacology 2008, 55:310-318.
11. Ginsberg M.D., Sternau L.L., Globus M.Y., Dietrich W.D., Busto R. Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc Brain Metabol Rev 1992, 4:189-225.
12. Hatfield R.H., Mendelow A.D., Perry R.H., Alvarez L.M., Modha P. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol Appl Neurobiol 1991, 17:61-67.
13. Hemmings H.H., Akabas M.H., Goldstein P.A., Trudell J.R., Orser B.A., Harrison N.L. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 2005, 26:503-510.
14. Isayama K., Pitts L.H., Nishimura M.C. Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 1991, 22:1394-1398.
15. Kitano H., Kirsch J.R., Hurn P.D., Murphy S.J. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 2007, 27:1108-1128.
16. Lieb K., Andrae J., Reisert I., Pilgrim C. Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female dopaminergic neurons. Exp Neurol 1995, 134:222-229.
17. Liszczak T.M., Hedley-Whyte E.T., Adams J.F., Han D.H., Kolluri V.S., Vacanti F.X., et al. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol 1984, 65:150-157.
18. McGee-Russell S.M., Brown A.W., Brierley J.B. A combined light and electron microscope study of early anoxic-ischaemic cell change in rat brain. Brain Res 1970, 20:193-200.
19. McCulloch J. Glutamate receptor antagonists in cerebral ischaemia. J Neural Transm 1994, 43:71-79.
20. Mathews K.S., McLaughlin D.P., Ziabari L.H., Toner C.C., Street P.C., Hisgrove E., et al. Rapid quantification of ischaemic injury and cerebroprotection in brain slices using densitometric assessment of 2,3,5-triphenyltetrazolium chloride staining. J Neurosci Methods 2000, 102:43-51.
21. NICE Stroke, diagnosis and initial management of acute stroke and transient ischaemic attack (TIA) 2008.
22. Richards D.A., Obrenovitch T.P., Johonson-Mora A., Islekel S., Symon L., Curzon G. Effect of global ischaemia under simulated penumbral conditions on brain monoamine neurochemistry and subsequent neurological and histological deficits. J Neurochem 1993, 61:1801-1807.
23. Sarna G.S., Obrenovitch T.P., Matsumoto T., Symon L., Curzon G. Effect of transient cerebral ischaemia and cardiac arrest on brain extracellular dopamine and serotonin as determined by in vivo dialysis in the rat. J Neurochem 1990, 55:937-940.
24. Schurr A., West C.A., Tseng M.T., Reid K.H., Rigor B.M. The role of glucose in maintaining synaptic activity in the rat hippocampal slice preparation. Brain slices: fundamentals, applications and implications 1986, 39-44. Karger, Basel. 1st ed. A. Schurr, T.J. Teyler, M.T. Tseng (Eds.).
25. Schurr A., West C.A., Reid K.H., Tseng M.T., Reiss S.J., Rigor B.M. Increased glucose improves recovery of neuronal function after cerebral hypoxia in vitro. Brain Res 1987, 421:135-139.
26. Schurr A., West C.A., Rigor B.M. Lactate-supported synaptic function in the rat hippocampal slice preparation. Science 1988, 240:1326-1328.
27. Stamford J.A. Fast cyclic voltammetry: measuring transmitter release in 'real time'. J Neurosci Methods 1990, 34:67-72.
28. Stamford J.A., Palij P., Davidson C., Jorm C.M., Millar J. Simultaneous "real-time" electrochemical and electrophysiological recording in brain slices with a single carbon-fibre microelectrode. J Neurosci Methods 1993, 50:279-290.
29. Stamford J.A., Palij P., Davidson C., Jorm C.M., Phillips P.E.M. Fast cyclic voltammetry in brain slices. Voltammetric methods in brain systems 1995, 82-114. Humana Press, Totowa, NJ, USA. 27th ed. A.A. Boulton, G.B. Baker, R.N. Adams (Eds.).
30. Toner C.C., Stamford J.A. 'Real time' measurement of dopamine release in an in vitro model of neostriatal ischaemia. J Neurosci Methods 1996, 67:133-140.
31. Toner C.C., Stamford J.A. General anaesthetics as neuroprotective agents. Baillière's Clin Anaesthesiol 1996, 10:515-533.
32. Toner C.C., Stamford J.A. Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia. Brain Res Bull 1999, 48:395-399.
33. Toner C.C., Connelly K., Whelpton R., Bains S., Michael-Titus A.T., McLaughlin D.P., et al. Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. Br J Anaesth 2001, 86:550-554.
34. Toner C.C., Milne A.J., Blatchford K.L., McLaughlin D.P., Stamford J.A. An assessment of the cerebroprotective potential of volatile anaesthetics using two independent methods in an in vitro model of cerebral ischaemia. Brain Res 2002, 958:390-398.
35. Young A.M.J. Increased extracellular dopamine in nucleus accumbens in response to unconditioned and conditioned aversive stimuli: studies using 1min microdialysis in rats. J Neurosci Methods 2004, 138:57-63.